Division of Cardiovascular and Diabetes Research, University of Leeds, Leeds, UK.
Diabetes Care. 2012 Apr;35(4):894-9. doi: 10.2337/dc11-1483. Epub 2012 Feb 14.
Emerging data implicate activation of the complement cascade in the pathogenesis of type 2 diabetes. The objective of the current study was to evaluate the relationships between components of the complement system, metabolic risk factors, and family history of type 2 diabetes in healthy South Asians.
We recruited 119 healthy, first-degree relatives of South Asian subjects with type 2 diabetes (SARs) and 119 age- and sex-matched, healthy South Asian control subjects (SACs). Fasting blood samples were taken for measurement of complement factors and standard metabolic risk factors.
SARs were characterized by significantly higher properdin (mean concentration 12.6 [95% CI 12.2-13.1] mg/L vs. SACs 10.1 [9.7-10.5] mg/L, P < 0.0001), factor B (187.4 [180.1-195.0] mg/L vs. SACs 165.0 [158.0-172.2] mg/L, P < 0.0001), and SC5b-9 (92.0 [86.1-98.3] ng/mL vs. SACs 75.3 [71.9-78.9] ng/mL, P < 0.0001) and increased homeostasis model assessment of insulin resistance (2.86 [2.61-3.13] vs. SACs 2.31 [2.05-2.61], P = 0.007). C-reactive protein did not differ between SARs and SACs (P = 0.17). In subgroup analysis of 25 SARs and 25 SACs with normal oral glucose tolerance tests, properdin, factor B, and SC5b-9 remained significantly elevated in SARs.
Increased properdin and complement activation are associated with a family history of type 2 diabetes in South Asians independent of insulin resistance, and predate the development of impaired fasting glucose and impaired glucose tolerance. Properdin and SC5b-9 may be novel biomarkers for future risk of type 2 diabetes in this high-risk population and warrant further investigation.
新出现的数据表明,补体级联的激活与 2 型糖尿病的发病机制有关。本研究的目的是评估补体系统成分、代谢危险因素与 2 型糖尿病南亚裔一级亲属(SARs)之间的关系。
我们招募了 119 名健康的 SARs 和 119 名年龄和性别匹配的健康南亚裔对照者(SACs)。采集空腹血样以测量补体因子和标准代谢危险因素。
SARs 的特征是特异性升高的备解素(平均浓度 12.6 [95%CI 12.2-13.1] mg/L 与 SACs 10.1 [9.7-10.5] mg/L,P < 0.0001)、因子 B(187.4 [180.1-195.0] mg/L 与 SACs 165.0 [158.0-172.2] mg/L,P < 0.0001)和 SC5b-9(92.0 [86.1-98.3] ng/mL 与 SACs 75.3 [71.9-78.9] ng/mL,P < 0.0001),且胰岛素抵抗的稳态模型评估值升高(2.86 [2.61-3.13] 与 SACs 2.31 [2.05-2.61],P = 0.007)。SARs 和 SACs 之间的 C 反应蛋白无差异(P = 0.17)。在 25 名 SARs 和 25 名正常口服葡萄糖耐量试验的 SACs 的亚组分析中,SARs 中备解素、因子 B 和 SC5b-9 仍然显著升高。
在南亚裔人群中,补体激活与 2 型糖尿病家族史相关,且与胰岛素抵抗无关,早于空腹血糖受损和糖耐量受损的发生。备解素和 SC5b-9 可能是该高危人群未来发生 2 型糖尿病的新的生物标志物,值得进一步研究。